We have located links that may give you full text access.
Negative payoffs of upper gastrointestinal endoscopy in patients admitted under observation status.
Minerva Gastroenterologica e Dietologica 2018 October 3
BACKGROUND: More than 70 million americans (23% of the US population) have non-cardiac chest pain at least once in their lifetime with gastroesophageal reflux disease (GERD) being the leading cause (37-66%). Current guidelines support the use of a proton pump inhibitor (PPI) prior to invasive or noninvasive testing as a diagnostic, therapeutic and cost effective method as a part of High Value Care recommendations.
METHODS: We performed a chart review of 126 patients admitted to the hospital under observation status who underwent upper GI endoscopies in the hospital at 3 different urban community hospitals. This was compared with 260 patients admitted who didn't have this procedure done. We calculated the healthcare burden including length of stay, reimbursement and complications from the procedures/extra stay in the hospital.
RESULTS: The direct cost per case was almost two times in the group that underwent the procedure as compared to the group that did not. The mean LOS was higher in the group that underwent the endoscopies. There were no complications and there was no difference in mortality.
CONCLUSIONS: Upper gastrointestinal endoscopy in patients with atypical chest pain of GI origin as an initial step is a significant healthcare burden and contradicts the currently recommended High Value Care recommendations. Our study delineates this large negative financial impact when performing upper endoscopies under observation status. Such patients should be started on an empirical trial of PPI, and endoscopy should be reserved for patients whose symptoms are unresponsive to PPIs or have alarm features.
METHODS: We performed a chart review of 126 patients admitted to the hospital under observation status who underwent upper GI endoscopies in the hospital at 3 different urban community hospitals. This was compared with 260 patients admitted who didn't have this procedure done. We calculated the healthcare burden including length of stay, reimbursement and complications from the procedures/extra stay in the hospital.
RESULTS: The direct cost per case was almost two times in the group that underwent the procedure as compared to the group that did not. The mean LOS was higher in the group that underwent the endoscopies. There were no complications and there was no difference in mortality.
CONCLUSIONS: Upper gastrointestinal endoscopy in patients with atypical chest pain of GI origin as an initial step is a significant healthcare burden and contradicts the currently recommended High Value Care recommendations. Our study delineates this large negative financial impact when performing upper endoscopies under observation status. Such patients should be started on an empirical trial of PPI, and endoscopy should be reserved for patients whose symptoms are unresponsive to PPIs or have alarm features.
Full text links
Related Resources
Trending Papers
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app